Need for Extensive and Reliable Identification of Proteins Is Now Widely Recognized Screening technologies for proteins are still gaining momentum, and as the discipline matures scientists are ...
Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.
DUBLIN--(BUSINESS WIRE)--The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), ...
New research from The Wistar Institute's Montaner lab—led by Wistar Executive Vice President, director of the HIV Cure and Viral Disease Center, and Herbert Kean, M.D., Family Professor, Luis Montaner ...
An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...
In April, the FDA announced an ambitious plan to phase out animal testing requirements for monoclonal antibodies and other therapies in an effort to improve drug safety and reduce R&D costs. The goal ...
Scientists have identified human antibodies capable of targeting the proteins responsible for severe malaria, potentially paving the way for new vaccines or treatments. Using organ-on-a-chip ...
At an old biscuit factory in South London, giant mixers and industrial ovens have been replaced by robotic arms, incubators, and DNA sequencing machines. James Field and his company LabGenius aren’t ...
Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year – most of them African children under five. In a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results